Xue S - Search Results

1

SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity.

Wang F, Gao Y, Xue S, Zhao L, Jiang H, Zhang T, Li Y, Zhao C, Wu F, Siqin T, Liu Y, Wu J, Yan Y, Yuan J, Jiang JD, Li K. Wang F, et al. Among authors: xue s. Nat Commun. 2023 Sep 22;14(1):5917. doi: 10.1038/s41467-023-41593-z. Nat Commun. 2023. PMID: 37739936 Free PMC article.

2

Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure-activity relationships, and preventive bone loss efficacies in senescence accelerated mice (SAMP6) and ovariectomized rats.

Guo HF, Shao HY, Yang ZY, Xue ST, Li X, Liu ZY, He XB, Jiang JD, Zhang YQ, Si SY, Li ZR. Guo HF, et al. J Med Chem. 2010 Feb 25;53(4):1819-29. doi: 10.1021/jm901685n. J Med Chem. 2010. PMID: 20088515

3

Synthesis and anti-influenza virus activities of a novel class of gastrodin derivatives.

Xue ST, He WY, Ma LL, Wang HQ, Wang B, Zheng GH, Ji XY, Zhang T, Li YH, Jiang JD, Li ZR. Xue ST, et al. Molecules. 2013 Mar 26;18(4):3789-805. doi: 10.3390/molecules18043789. Molecules. 2013. PMID: 23531598 Free PMC article.

4

The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.

Xue ST, Li K, Gao Y, Zhao LY, Gao Y, Yi H, Jiang JD, Li ZR. Xue ST, et al. Autophagy. 2020 Oct;16(10):1823-1837. doi: 10.1080/15548627.2019.1709762. Epub 2020 Jan 27. Autophagy. 2020. PMID: 31986961 Free PMC article.

5

Structure-Based Virtual Screening towards the Discovery of Novel ULK1 Inhibitors with Anti-HCC Activities.

Gao Y, Zhou Z, Zhang T, Xue S, Li K, Jiang J. Gao Y, et al. Among authors: xue s. Molecules. 2022 Apr 19;27(9):2627. doi: 10.3390/molecules27092627. Molecules. 2022. PMID: 35565977 Free PMC article.

6

BMP2-ERK-ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis.

Zhou Z, Zhao C, Li S, Han X, Zhu J, Xue S, Li Z. Zhou Z, et al. Among authors: xue s. Int J Mol Sci. 2024 Mar 15;25(6):3350. doi: 10.3390/ijms25063350. Int J Mol Sci. 2024. PMID: 38542323 Free PMC article.

7

Design and synthesis of dabigatran etexilate derivatives with inhibiting thrombin activity for hepatocellular carcinoma treatment.

Xie ZS, Han XY, Zhou ZY, Li SY, Zhu JY, Zhang L, Xue ST. Xie ZS, et al. Biomed Pharmacother. 2024 Jan;170:116018. doi: 10.1016/j.biopha.2023.116018. Epub 2023 Dec 18. Biomed Pharmacother. 2024. PMID: 38113628 Free article.

8

Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer.

Zhang Z, Xue ST, Gao Y, Li Y, Zhou Z, Wang J, Li Z, Liu Z. Zhang Z, et al. Cell Death Discov. 2022 Jun 9;8(1):280. doi: 10.1038/s41420-022-01070-w. Cell Death Discov. 2022. PMID: 35680842 Free PMC article.

9

Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer.

Zhou ZY, Han XY, Sun LQ, Li SY, Xue ST, Li ZR. Zhou ZY, et al. Front Chem. 2022 Nov 24;10:1058256. doi: 10.3389/fchem.2022.1058256. eCollection 2022. Front Chem. 2022. PMID: 36505747 Free PMC article.

10

Advances in inhibitors of potential tumor target FOXM1.

Han XY, Zhou ZY, Li SY, Xue ST. Han XY, et al. Future Med Chem. 2023 May;15(10):809-812. doi: 10.4155/fmc-2023-0118. Epub 2023 May 25. Future Med Chem. 2023. PMID: 37226453 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,966 results

Search Page